Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

294 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rapid screening of COVID-19 patients using white blood cell scattergrams, a study on 381 patients.
Osman J, Lambert J, Templé M, Devaux F, Favre R, Flaujac C, Bridoux D, Marque-Juillet S, Bruneel F, Mignon F, Diaz-Flores E, Hentgen V, Greder-Belan A, Azarian R, Koukabi M, Rousselot P, Raggueneau V, Manéglier B. Osman J, et al. Among authors: temple m. Br J Haematol. 2020 Sep;190(5):718-722. doi: 10.1111/bjh.16943. Epub 2020 Jul 5. Br J Haematol. 2020. PMID: 32542672 Free PMC article.
Clinico-biological features, treatment and prognosis of primary myeloid sarcoma: A French retrospective multi-centric observational study.
Belhadj M, Burroni B, Kosmider O, Willems L, Temple M, Bertoli S, Orvain C, Dumas PY, Berthon C, Gabellier L, Marcais A, Raffoux E, Pautas C, Genthon A, Decroocq J, Birsen R, Tamburini J, Bouscary D, Contejean A. Belhadj M, et al. Among authors: temple m. Br J Haematol. 2023 Sep;202(6):e50-e53. doi: 10.1111/bjh.18961. Epub 2023 Jul 4. Br J Haematol. 2023. PMID: 37403204 No abstract available.
Comparison of prognostic scores according to WHO classification in 170 patients with advanced mastocytosis and C-finding treated with midostaurin.
Heiblig M, Gourguechon C, Guilpain P, Bulai-Livideanu C, Barete S, Chantran Y, Agopian J, Brenet F, Dubreuil P, Lespinasse J, Lemal R, Tournilhac O, Terriou L, Launay D, Bouillet L, Chatain C, Damaj G, Ballul T, Greco C, Polivka L, Frenzel L, Meni C, Bouktit H, Benabou D, Gaudy-Marqueste C, Gousseff M, Le Mouel E, Neel A, Ranta D, Jaussaud R, Molina TJ, Bruneau J, Villarese P, Lhermitte L, Maouche-Chrétien L, Temple M, Kosmider O, Javier RM, Pelletier F, Castelain F, Retornaz F, Cabrera Q, Zunic P, Gourin MP, Wierzbicka-Hainaut E, Viallard JF, Lavigne C, Hoarau C, Durieu I, Dimicoli-Salazar S, Torregrosa-Diaz JM, Wemeau M, Soria A, Arock M, Bodemer C, Lortholary O, Hermine O, Rossignol J. Heiblig M, et al. Among authors: temple m. Am J Hematol. 2024 Nov;99(11):2127-2139. doi: 10.1002/ajh.27478. Epub 2024 Sep 17. Am J Hematol. 2024. PMID: 39287048
Atypical splice-site mutations causing VEXAS syndrome.
Templé M, Duroyon E, Croizier C, Rossignol J, Huet T, Friedrich C, Zalmai L, Priollet P, Hayem G, Tournillhac O, Le Guenno G, Hermine O, Terrier B, Kosmider O. Templé M, et al. Rheumatology (Oxford). 2021 Dec 1;60(12):e435-e437. doi: 10.1093/rheumatology/keab524. Rheumatology (Oxford). 2021. PMID: 34213531 No abstract available.
Pleuropulmonary Manifestations of Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome.
Borie R, Debray MP, Guedon AF, Mekinian A, Terriou L, Lacombe V, Lazaro E, Meyer A, Mathian A, Ardois S, Vial G, Moulinet T, Terrier B, Jamilloux Y, Heiblig M, Bouaziz JD, Zakine E, Outh R, Groslerons S, Bigot A, Flamarion E, Kostine M, Henneton P, Humbert S, Constantin A, Samson M, Bertrand NM, Biscay P, Dieval C, Lobbes H, Jeannel J, Servettaz A, Adelaide L, Graveleau J, de Sainte-Marie B, Galland J, Guillotin V, Duroyon E, Templé M, Bourguiba R, Georgin Lavialle S, Kosmider O, Audemard-Verger A; French VEXAS Group. Borie R, et al. Among authors: temple m. Chest. 2023 Mar;163(3):575-585. doi: 10.1016/j.chest.2022.10.011. Epub 2022 Oct 20. Chest. 2023. PMID: 36272567
Trismus as a new feature of VEXAS syndrome.
Archambeaud A, Le Dreau C, Bigot A, Kosmider O, Taleb A, Boucher L, Temple M, Cottier JP, Maillot F, Audemard-Verger A. Archambeaud A, et al. Among authors: temple m. Rheumatology (Oxford). 2024 Sep 1;63(9):e258-e260. doi: 10.1093/rheumatology/keae135. Rheumatology (Oxford). 2024. PMID: 38450422 No abstract available.
VEXAS Syndrome: A Novelty in MDS Landscape.
Templé M, Kosmider O. Templé M, et al. Diagnostics (Basel). 2022 Jun 29;12(7):1590. doi: 10.3390/diagnostics12071590. Diagnostics (Basel). 2022. PMID: 35885496 Free PMC article. Review.
Systematic search for the UBA1 mutation in men after a first episode of venous thromboembolism: A monocentric study.
Khider L, Templé M, Bally C, Spaeth A, Darnige L, Sanchez O, Planquette B, Mortelette H, Messas E, Smadja DM, Emmerich J, Mirault T, Kosmider O, Gendron N. Khider L, et al. Among authors: temple m. J Thromb Haemost. 2022 Nov;20(11):2697-2699. doi: 10.1111/jth.15858. Epub 2022 Sep 13. J Thromb Haemost. 2022. PMID: 36002395 Free PMC article. No abstract available.
294 results